CERTAIN, NCT06035055: Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis |
|
|
| Not yet recruiting | 4 | 30 | NA | Ceftolozane/tazobactam | Sunshine Coast Hospital and Health Service, The Prince Charles Hospital, Mater | Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa, Burkholderia Cepacia Infection | 10/23 | 01/24 | | |
| Active, not recruiting | 3 | 2200 | RoW | (Arm Closed) Nafamostat Mesilate, Nafabelltan, (Arm Closed) Enoxaparin, (Arm Closed) Dalteparin, (Arm Closed) Tinzaparin, (Arm Never Opened) Hyperimmune globulin, Nirmatrelvir-Ritonavir, Paxlovid, Remdesivir, Veklury | University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Australasian Society for Infectious Diseases, Hunter Medical Research Institute, Aotearoa Clinical Trials, Australian and New Zealand Intensive Care Research Centre | SARS-CoV-2 Infection (COVID-19) | 07/25 | 12/25 | | |
